← back to search

Jan J. Jobsen

Utrecht University · NL
🔎 Find collaborators in Obstetrics and Gynecology · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Obstetrics and Gynecology · Cancer Research
Research interest
Research focused on Endometrial cancer and Hazard ratio, with related work in Breast cancer, PTEN, Randomized controlled trial. Notable publications include 'Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer', 'L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results', and 'Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)'.
h-index
—
citations
872
works
8
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
Clinical Cancer Research 2023cited by 32position: middledoi
Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)
Breast Cancer Research 2022cited by 103position: middledoi
Effect of physical exercise on the hippocampus and global grey matter volume in breast cancer patients: A randomized controlled trial (PAM study)
NeuroImage Clinical 2022cited by 16position: middledoi
Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer
International Journal of Gynecological Pathology 2021cited by 81position: middledoi
Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
Cancer Immunology Research 2020cited by 85position: middledoi
Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
JNCI Journal of the National Cancer Institute 2014cited by 336position: middledoi
L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
European Journal of Cancer 2014cited by 159position: middledoi
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation
Gynecologic Oncology 2012cited by 60position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Remi A. Nout · Erasmus MC6 papers (2012–2023)Tjalling Bosse · Eurofins (Denmark)6 papers (2012–2023)Carien L. Creutzberg · Stanford University6 papers (2012–2023)Vincent T.H.B.M. Smit · Erasmus MC5 papers (2012–2021)Ina M. Jürgenliemk‐Schulz · Utrecht University4 papers (2012–2021)Ludy Lutgens · Maastro Clinic4 papers (2012–2023)Elzbieta M. van der Steen‐Banasik · Utrecht University3 papers (2012–2021)Ellen Stelloo · Utrecht University3 papers (2014–2020)Natalja T. ter Haar · KU Leuven2 papers (2012–2014)Alicia León‐Castillo · Leiden University Medical Center2 papers (2020–2021)Hans W. Nijman · University Medical Center Groningen2 papers (2014–2020)Jan Willem Mens · Utrecht University2 papers (2021–2023)David N. Church · Centre for Human Genetics2 papers (2014–2020)Nanda Horeweg · 2 papers (2020–2023)Ina Jürgemlienk-Schulz · Utrecht University1 papers (2023–2023)Ì.M. Jürgenliemk-Schulz · Utrecht University1 papers (2014–2014)— · 1 papers (2020–2020)— · 1 papers (2014–2014)Nadejda Valtcheva · KU Leuven1 papers (2014–2014)Viktor H. Koelzer · University of Basel1 papers (2020–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Obstetrics and Gynecology · Cancer Research →